Jacky Chen
General Manager @ BioVenture
Suzhou, China
Jacky Chen is a startup investor at BioVenture in Suzhou. With 20 years of experience in MNCs and investment sector. Previously held the positions of Business Development Director, China Head, Investment VP and Managing Director at:MNCs such as A.T.Kkearney, SHELL, General Electric, Philips, and Syngenta CXC Capital, Managing Director ($200 million fund)GL Capital, Senior VP ($450 million fund)Olympus Capital, China Head ($1 billion fund)Investment Sample Cases before bioVENTURE:Pharmaron (CRO), BGI (Already exit by selling old share)Kangchen Pharma (exited), Gan-Lee Pharma, Jingfeng Pharma (IPO)Arrail Dental, Zhejiang Kangning Hospital (IPO)HC SemiTek (Listed company code: 300323)MBA from Cornell University (US); Bachelor from Zhongshan University
Last updated:
For AI agents: llms.txt
About BioVenture
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
BioVenture Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Erik Hoppe
Executive Partner
|
|||
|
Chen Jie
Founding Partner
|
|||
Gaojian Ning
Investment Director
|
|||
Haihua Huang
Investment Director
|
|||
|
Jacky Chen
General Manager
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
